Effects of histamine on pulmonary artery system in humans after pretreatment with an H2-receptor-antagonist
Kruse, K.M.; Huber, T.; Grosse-Heitmeyer, W.
International Journal of Clinical Pharmacology Therapy and Toxicology 30(11): 445-446
1992
ISSN/ISBN: 0174-4879 PMID: 1362716 Document Number: 397009
Document emailed within 1 workday
Related Documents
Meyer, B.H.; Müller, F.O.; Badian, M.; Hundt, H.K.; Joubert, A.L.; Luus, H.G. 1988: Effects of HOE 760 (histamine H2-receptor antagonist) on diazepam pharmacokinetics South African Medical Journal 73(7): 421-423Ligneau, X.; Lin, J.; Vanni-Mercier, G.; Jouvet, M.; Muir, J.L.; Ganellin, C.R.; Stark, H.; Elz, S.; Schunack, W.; Schwartz, J. 1998: Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist Journal of Pharmacology and Experimental Therapeutics 287(2): 658-666
Palop, D.; Agut, J.; Márquez, M.; Conejo, L.; Sacristán, A.; Ortiz, J.A. 1997: Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat Arzneimittel-Forschung 47(4a): 439-446
Bu, X.; Wang, C.; Pang, B. 2003: Effects of leukotriene receptor antagonist on chronic obstructive [correction of obstractive] pulmonary disease induced pulmonary hypertension Chinese Medical Journal 116(3): 459-461
Kamada, T.; Kusunoki, H.; Manabe, N.; Shiotani, A.; Hata, J.; Haruma, K. 2007: Histamine-2 receptor antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 65(10): 1835-1840
Sekiguchi, H.; Hamada, K.; Taga, F.; Nishino, K. 1993: Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats Arzneimittel-Forschung 43(2): 134-138
Wyllie, J.H. 1978: Histamine H2-receptor antagonist in treatment of peptic ulcer Postgraduate Medicine 63(4): 91
Brimblecombe, R.W.; Duncan, W.A.; Durant, G.J.; Emmett, J.C.; Ganellin, C.R.; Leslie, G.B.; Parsons, M.E. 1978: Characterization and development of cimetidine as a histamine H2-receptor antagonist Gastroenterology 74(2 Part 2): 339-347
Fisas, M.A.; Gutiérrez, B.; Fort, M.; Dordal, A.; García, C.; Farré, A.J. 1998: General pharmacological profile and effects of E-4716, a novel histamine receptor blocker, on the central nervous system Methods and Findings in Experimental and Clinical Pharmacology 20(3): 199-210
Poizot, A.; Dumez, D.; Ferrandon, P.; Lefournier, C.; Michel, A.; Armstrong, J.M. 1986: Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline Arzneimittel-Forschung 36(4): 695-702
Franz, P.M.; Mattiuz, E.L.; Hatcher, B.L.; DeSante, K.A.; Breau, A.P.; Occolowitz, J.L.; Dorman, D.E.; Schmid, C.R.; Goldberg, M.J.; Rubin, A. 1993: Disposition of zatosetron, a serotonin (5-HT3) receptor antagonist, in humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(2): 249-254
Barbezat, G.O.; Bank, S. 1976: Effect of a histamine H2-receptor antagonist and an anticholinergic on gastric acid secretion in man South African Medical Journal 50(22): 849-851
Necciari, J.; Mery, D.; Garriot, P.; Escourrou, J.; Cautreels, W. 1985: Pharmacokinetics of CM 57755, a new histamine H2-receptor antagonist, after single oral doses in man International Journal of Clinical Pharmacology Research 5(6): 457-465
Zak-Nejmark, T.; Małolepszy, J.; Nadobna, G.; Kuczyńska-Sekieta, K.; Marczyńska-Sarul, E.; Jutel, M. 1992: Specific immunotherapy stimulates the binding of histamine H2 receptor antagonist by lymphocytes Archivum Immunologiae et Therapiae Experimentalis 40(2): 113-116
Klima, P. 1984: Experiences with the histamine-H2-receptor antagonist ranitidine in the prevention of stress ulcers Wiener Medizinische Wochenschrift 134(15-16): 369-373
Inamori, M.; Iida, H.; Hosono, K.; Endo, H.; Sakamoto, Y.; Takahashi, H.; Koide, T.; Tokoro, C.; Goto, A.; Abe, Y.; Hiratsuka, N.; Nakajima, A.; Fujita, M. 2010: The histamine H2 receptor antagonist lafutidine in Japanese patients with non-erosive reflux disease Hepato-Gastroenterology 57(104): 1430-1434
Kishimoto, W.; Hiroi, T.; Sakai, K.; Funae, Y.; Igarashi, T. 1997: Metabolism of epinastine, a histamine H1 receptor antagonist, in human liver microsomes in comparison with that of terfenadine Research Communications in Molecular Pathology and Pharmacology 98(3): 273-292
Liu, G.; Liu, Z.; Song, Y.; Yu, R. 2000: Quantitative evaluation of dyspnea and the effects of M-receptor antagonist on dyspnea in patients with chronic obstructive pulmonary disease Zhonghua Nei Ke Za Zhi 39(12): 828-830
Cieślewicz, G.; Gondorowicz, K.; Grzelewska-Rzymowska, I.; Rozniecki, J.; Wojciechowska, B. 1992: Effect of loratadine--selective antagonist of histamine (H1) receptor--on allergen-induced bronchoconstriction in atopic asthmatics Pneumonologia i Alergologia Polska 60(11-12): 11-15
Katz, L.B.; Scott, C.K.; Shriver, D.A. 1986: Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine Journal of Pharmacology and Experimental Therapeutics 238(2): 587-593